Clinical Trials for Circulating Tumor DNA

Find clinical trials for circulating tumor dna. Discover research opportunities and treatment options in your area.

16 Active Trials Found

Showing 16 trials on this page

Page 1 of 1

ctDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases

NCT ID: NCT05787197

This clinical trial is studying the role of a specific type of blood test called circulating tumor DNA (ctDNA) in patients with metastatic colorectal cancer who are about to undergo surgery to remo...

Recruiting

Type: observational Locations: Villejuif, , France, Paris, , France +14 more

Circulating Tumor DNA Based Adjuvant Chemotherapy in Stage II Colon Cancer Patients: the MEDOCC-CrEATE Trial

NCT ID: NCT06434896

The MEDOCC-CrEATE Trial is a research study that focuses on patients with stage II colon cancer who are not typically recommended for additional chemotherapy after surgery. This trial is looking at...

Recruiting

Phase: NA Type: interventional Locations: Deventer, , Netherlands, Ede, , Netherlands +27 more

Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer

NCT ID: NCT05601505

This clinical trial is studying a new treatment approach for patients with locally advanced rectal cancer. The goal is to see if using a special test that detects circulating tumor DNA (ctDNA) can ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, Beijing, China

CtDNA as a Novel Biomarker of Treatment Efficacy in Patients With Ovarian Cancer

NCT ID: NCT05027828

This clinical trial is investigating how a new test that looks for circulating tumor DNA (ctDNA) can help doctors understand how well a specific treatment works for women with high-grade serous ova...

Recruiting

Type: observational Locations: Shanghai, , China

Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)

NCT ID: NCT05598528

The PRECISE Study is a clinical trial aimed at understanding why some patients with advanced non-small cell lung cancer (NSCLC) do not respond to a specific type of medication called third-generati...

Recruiting

Type: observational Locations: Changsha, Hunan, China

NSCLC Liquid Biopsies and Exhaled VOC

NCT ID: NCT06707519

This clinical trial is looking at new ways to detect changes in lung cancer using different types of samples. Researchers want to see if they can find cancer-related changes in sputum (mucus from t...

Recruiting

Type: observational Locations: Hamilton, Ontario, Canada

Danish Vulva Cancer Recurrence Study

NCT ID: NCT06495554

The Danish Vulva Cancer Recurrence Study, also known as DaVulvaRec, is a research project aimed at improving how we detect and manage the return of vulva cancer in women. This study will look at va...

Recruiting

Phase: NA Type: interventional Locations: Copenhagen, , Denmark, Aarhus N, , Denmark

Clinical Application of ctDNA Dynamic Monitoring in Neoadjuvant Therapy for HER2-positive Breast Cancer Patients

NCT ID: NCT06479460

This clinical trial is looking at how a special test called circulating tumor DNA (ctDNA) can help doctors understand how well treatment is working for women with a specific type of breast cancer k...

Recruiting

Type: observational Locations: Nanjing, Jiangsu, China

Using ctDNA to Determine Therapies for Lung Cancer

NCT ID: NCT04966663

This clinical trial is looking at how a test that detects circulating tumor DNA (ctDNA) in the blood can help doctors decide if additional treatment after surgery can lower the risk of lung cancer ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Toronto, Ontario, Canada, Toronto, Ontario, Canada

Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer

NCT ID: NCT04530890

The ADIGYN study is focused on understanding the role of circulating tumor DNA (ctDNA) and exosomes in patients with digestive, gynecological, and breast cancers. ctDNA is a type of genetic materia...

Recruiting

Phase: NA Type: interventional Locations: Poitiers, , France

ctDNA Methylation for Epithelial Ovarian Cancer

NCT ID: NCT05801263

This clinical trial, called the OVAMethy study, is focused on finding a better way to diagnose and monitor epithelial ovarian cancer, which is a serious type of cancer in women. Researchers want to...

Recruiting

Type: observational Locations: Beijing, Beijing, China

ctDNA Methylation for Detecting Ovarian Cancer

NCT ID: NCT05801276

This clinical trial is investigating a new method to detect ovarian cancer using a simple blood test. Researchers are focusing on specific changes in DNA—called methylation—that can indicate the pr...

Recruiting

Type: observational Locations: Beijing, Beijing, China

Circulating Tumor DNA Guided Adjuvant Chemotherapy for Colon Cancer

NCT ID: NCT05529615

This clinical trial, titled "Circulating Tumor DNA Guided Adjuvant Chemotherapy for Colon Cancer," is investigating how circulating tumor DNA (ctDNA) can help doctors decide the best chemotherapy t...

Recruiting

Phase: NA Type: interventional Locations: Beijing, Beijing, China

Circulating Tumor DNA Guided Therapeutic Strategies for CRC Patients With Small Pulmonary Nodules

NCT ID: NCT05495672

This clinical trial is looking at how using a special blood test, called circulating tumor DNA (ctDNA) testing, can help doctors make better treatment decisions for patients with advanced colorecta...

Recruiting

Phase: NA Type: interventional Locations: Shanghai, , China, Shanghai, Shanghai, China

IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer

NCT ID: NCT03748680

The IMPROVE Intervention Trial is a study that aims to improve treatment for patients with colorectal cancer by analyzing a specific type of genetic material called circulating tumor DNA (ctDNA) af...

Recruiting

Phase: PHASE2 Type: interventional Locations: Aarhus, , Denmark, Odense, , Denmark +2 more

The Value of ctDNA on Chemotherapy Efficacy for mCRC

NCT ID: NCT04555369

This clinical trial is studying how well a specific test called ctDNA (circulating tumor DNA) can predict how effective chemotherapy will be for patients with advanced colorectal cancer that has sp...

Recruiting

Phase: NA Type: interventional Locations: Shanghai, Shanghai, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions